Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JQ.2.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JQ.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JQ.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.2.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.23.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.23.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DY.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LE.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
MD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LE.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDQORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.502ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.502ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.502ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.502NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.285ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used